ReviewFrontiers in endocrinology2019

Examining the Potential of Developing and Implementing Use of Adiponectin-Targeted Therapeutics for Metabolic and Cardiovascular Diseases.

Ying Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.